Andere talen Dr. Lal PathLabs Limited Bombay S.E.

Aandelen

LALPATHLAB

INE600L01024

Vertraagde tijd Bombay S.E. Andere beurzen 11:44:10 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2.248 ^INR	-3,33%		-4,82%	-12,78%

18/03	Dr Lal Pathlabs benoemt CEO	MT
17/03	Dr. Lal PathLabs Limited benoemt Shankha Banerjee tot Chief Executive Officer, met ingang van 21 mei 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Dr Lal Pathlabs Names CEO	18/03
Dr. Lal PathLabs Limited Appoints Shankha Banerjee as Chief Executive Officer, Effective May 21, 2024	17/03
Dr. Lal Pathlabs Limited Announces Resignation of Bharath U as Chief Executive Officer	03/03
Dr. Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q3; EPS, Revenue Miss Estimates	02/02
Dr. Lal PathLabs Seeks M&A	01/02
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests	01/02
Dr. Lal PathLabs Limited Approves Second Interim Dividend for the Fiscal Year 2023-24	01/02
Dr. Lal PathLabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01/02
Dr. Lal Pathlabs Board to Consider Second Interim Dividend for Fiscal 2024	25/01
Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q2; Shares Climb 5%	03/11
Dr. Lal PathLabs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	02/11
Dr. Lal Pathlabs Limited Approves to Declare Final Dividend for the Financial Year Ended March 31, 2023	12-09-23
Dr. Lal PathLabs Limited Announces Change in Directorate	20-08-23
Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q1; Revenue Meets Estimates	31-07-23
Dr. Lal PathLabs Seeks Inorganic Opportunity	27-07-23
Dr. Lal Pathlabs Limited Proposes Interim Dividend for the Financial Year 2023-24	27-07-23
Dr. Lal PathLabs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	27-07-23
Dr. Lal PathLabs Limited acquired additional 10% stake in Aprl Pathlabs Private Limited.	27-07-23
Dr. Lal PathLabs' Consolidated Net Profit Declines in Fiscal Q4; Shares Up 3%	12-05-23
Dr. Lal Pathlabs' Consolidated Profit Drops in Fiscal Q4	11-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Dr. Lal PathLabs Limited Bombay S.E.

Aandelen

LALPATHLAB

INE600L01024

Andere talen

Filters